Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting Modified Fournier Index by Using Artificial Neural Network in Central Europe.
Harsányi E, Bashir B, Alsilibe F, Moazzam MFU, Ratonyi T, Alsalman A, Széles A, Nyeki A, Takács I, Mohammed S. Harsányi E, et al. Among authors: bashir b. Int J Environ Res Public Health. 2022 Aug 26;19(17):10653. doi: 10.3390/ijerph191710653. Int J Environ Res Public Health. 2022. PMID: 36078383 Free PMC article.
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS).
Bashir B, Kwok S, Wierzbicki AS, Jones A, Dawson C, Downie P, Jenkinson F, Delaney H, Mansfield M, Datta D, Teoh Y, Hamilton P, Forrester N, O'Sullivan D, Ferdousi M, Durrington PN, AbdelRazik A, Gallo A, Moulin P, Soran H. Bashir B, et al. Atherosclerosis. 2024 Apr;391:117476. doi: 10.1016/j.atherosclerosis.2024.117476. Epub 2024 Feb 10. Atherosclerosis. 2024. PMID: 38447437
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma.
Beckermann KE, Patnaik A, Winer I, Tan W, Bashir B, Kyriakopoulos CE, Sweis RF, Chamberlain M, Rini BI. Beckermann KE, et al. Among authors: bashir b. Invest New Drugs. 2024 Apr;42(2):179-184. doi: 10.1007/s10637-024-01419-1. Epub 2024 Feb 19. Invest New Drugs. 2024. PMID: 38372949 Clinical Trial.
Historical reconstruction of inaccessibility status in Local Government Areas (LGAs) of Borno and Yobe States, Nigeria, 2010-2020.
Forbi JC, Musa MS, Salawu M, Idris JM, Ba'aba AI, Higgins J, Musa AI, Bashir B, Shettima A, Njeakor N, Uzoma I, Mshelia H, Nganda GW, Mohammed KI, Bomoi IM, Chiroma U, Kovacs SD, Biya O, Waziri NE, Aina M, Adamu US, Shuaib F, Bolu O, Franka R, Wiesen E. Forbi JC, et al. Among authors: bashir b. Pan Afr Med J. 2023 Jul 14;45(Suppl 2):7. doi: 10.11604/pamj.supp.2023.45.2.39332. eCollection 2023. Pan Afr Med J. 2023. PMID: 38370102 Free PMC article.
Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation.
Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto TJA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Bashir B, et al. Ageing Res Rev. 2024 Mar;95:102236. doi: 10.1016/j.arr.2024.102236. Epub 2024 Feb 16. Ageing Res Rev. 2024. PMID: 38369026 Review.
120 results